118 related articles for article (PubMed ID: 1917628)
1. Low dose rate irradiation and halogenated pyrimidine effects on human cervical carcinoma cells.
Tishler RB; Geard CR
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):975-82. PubMed ID: 1917628
[TBL] [Abstract][Full Text] [Related]
2. Correlation of sensitizer enhancement ratio with bromodeoxyuridine concentration and exposure time in human cervical carcinoma cells treated with low dose rate irradiation.
Tishler RB; Geard CR
Int J Radiat Oncol Biol Phys; 1992; 22(3):495-8. PubMed ID: 1735686
[TBL] [Abstract][Full Text] [Related]
3. BrdUrd-induced radiosensitization of two human tumour cell lines at iso-levels of incorporation.
Franken NA; Van Bree C; Kipp JB; Rodermond HM; Haveman J; Barendsen GW
Oncol Rep; 2000; 7(5):937-40. PubMed ID: 10948317
[TBL] [Abstract][Full Text] [Related]
4. Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma.
McLaughlin PW; Mancini WR; Stetson PL; Greenberg HS; Nguyen N; Seabury H; Heidorn DB; Lawrence TS
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):637-42. PubMed ID: 8330994
[TBL] [Abstract][Full Text] [Related]
5. The biological effect of pentoxifylline on the survival of human head and neck cancer cells treated with continuous low and high dose-rate irradiation.
Danielsson A; Karlsson E; Delle U; Helou K; Mercke C
J Cancer Res Clin Oncol; 2005 Jul; 131(7):459-67. PubMed ID: 15776273
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin and low dose rate irradiation in cisplatin resistant and sensitive human glioma cells.
Wilkins DE; Ng CE; Raaphorst GP
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):105-11. PubMed ID: 8823265
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of radiolabeled monoclonal antibody therapy using bromodeoxyuridine.
Buchsbaum DJ; Khazaeli MB; Davis MA; Lawrence TS
Cancer; 1994 Feb; 73(3 Suppl):999-1005. PubMed ID: 8306292
[TBL] [Abstract][Full Text] [Related]
8. Hypoxic cell sensitization: low-dose intrinsic radiosensitivity is predictive for etanidazole efficacy in a panel of human tumour cell lines.
Wouters BG; Sy AM; Skarsgard LD
Int J Radiat Biol; 1996 Dec; 70(6):719-33. PubMed ID: 8980670
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines.
Erlich E; McCall AR; Potkul RK; Walter S; Vaughan A
Gynecol Oncol; 1996 Feb; 60(2):251-4. PubMed ID: 8631547
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs.
Kinsella TJ; Dobson PP; Mitchell JB; Fornace AJ
Int J Radiat Oncol Biol Phys; 1987 May; 13(5):733-9. PubMed ID: 3570896
[TBL] [Abstract][Full Text] [Related]
11. Radiation survival of two human cervical carcinoma cell lines after multifraction irradiation.
Werts ED; Burholt DR; Paljug WR; Polizotto SL; Yann VM
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):941-50. PubMed ID: 8751403
[TBL] [Abstract][Full Text] [Related]
12. Use of fluorescence in situ hybridization (FISH) to study chromosomal damage induced by radiation and bromodeoxyuridine in human colon cancer cells.
Wilt SR; Burgess AC; Normolle DP; Trent JM; Lawrence TS
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):861-6. PubMed ID: 7960988
[TBL] [Abstract][Full Text] [Related]
13. Equivalence of pulsed-dose-rate to low-dose-rate irradiation in tumor and normal cell lines.
Niedbala M; Alsbeih G; Ng CE; Raaphorst GP
Radiat Res; 2001 Feb; 155(2):297-303. PubMed ID: 11175664
[TBL] [Abstract][Full Text] [Related]
14. Dose-rate effects between 0.3 and 30 Gy/h in a normal and a malignant human cell line.
Amdur RJ; Bedford JS
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):83-90. PubMed ID: 8083132
[TBL] [Abstract][Full Text] [Related]
15. Thermal sensitivity and radiosensitization in V79 cells after BrdUrd or IdUrd incorporation.
Raaphorst GP; Vadasz JA; Azzam EI
Radiat Res; 1984 Apr; 98(1):167-75. PubMed ID: 6718691
[TBL] [Abstract][Full Text] [Related]
16. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
17. The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells.
Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
Radiat Res; 1990 Aug; 123(2):192-8. PubMed ID: 2389005
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo radiation sensitization by the halogenated pyrimidine 5-chloro-2'-deoxycytidine.
Russell KJ; Rice GC; Brown JM
Cancer Res; 1986 Jun; 46(6):2883-7. PubMed ID: 3698014
[TBL] [Abstract][Full Text] [Related]
19. Linear-quadratic analysis of radiosensitization by halogenated pyrimidines. II. Radiosensitization of human colon cancer cells by bromodeoxyuridine.
Miller EM; Fowler JF; Kinsella TJ
Radiat Res; 1992 Jul; 131(1):90-7. PubMed ID: 1626053
[TBL] [Abstract][Full Text] [Related]
20. Iododeoxyuridine radiosensitization of human glioblastoma cells exposed to acute and chronic gamma irradiation: mechanistic implications and clinical relevance.
Schultz CJ; Gaffney DK; Lindstrom MJ; Kinsella TJ
Cancer J Sci Am; 1995; 1(2):151-61. PubMed ID: 9166468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
